The APAC intravenous immunoglobulin market is expected to grow from US$ 2,609.61 million in 2022 to US$ 4,156.85 million by 2028. It is estimated to grow at a CAGR of 8.1% from 2022 to 2028.
Strong Pipeline Candidates for IVIG
Leading players in the intravenous immunoglobulin market have multiple projects, and many biological products in pipelines are based on proprietary technology. For instance, Evolve Biologics aims to manufacture and market plasma-derived therapeutics using its proprietary PlasmaCap EBA purification technology. The company is developing a portfolio of product candidates, IVIG, which completed its Phase III clinical trial in February 2021. Similarly, Biotest is a global company that offers plasma protein products and biotherapeutic drugs. The company is developing IgG Next Generation, a newly developed polyvalent immunoglobulin preparation for intravenous administration from human plasma to treat immunodeficiencies and autoimmune diseases. In September 2020, the company completed its phase III trial investigating IgG Next Generation for patients with primary immunodeficiency disease (PID). Thus, strong pipeline candidates for IVIG are expected to become a trend in the intravenous immunoglobulin market.Market Overview
Asia Pacific (APAC) is the fastest-growing regional market for intravenous immunoglobulin. China, India, Japan, South Korea, Australia, and the Rest of APAC are the major contributors to the market in this region. Asia Pacific is likely to account for over 21.68% market share of the global intravenous immunoglobulin market in 2022 due to the increasing geriatric population, the rising prevalence of immune deficiency disorders, and the increasing adoption of immunoglobulin-based therapies for the treatment of primary immune deficiencies. Therefore, the region holds huge potential for the intravenous immunoglobulin market players to grow during the forecast period. China is a developing country in Asia Pacific with a well-established healthcare system and a fast-growing pharmaceutical industry. China is home to various medical, pharmaceutical, and biotechnology product manufacturing companies operating in the global market. China also has over 300 medical contract research organizations, along with prominent biopharmaceutical product manufacturers; including China Biologic Products Holdings, Inc. and Shanghai RAAS. These pharmaceutical companies are prone to global market competition, which encourages them to introduce innovative products, thereby boosting the growth of the intravenous immunoglobulin market.APAC Intravenous Immunoglobulin Market Segmentation
The APAC intravenous immunoglobulin market is segmented into type, application, distribution channel, end user, and country. Based on type, the market is segmented into IgG, IgM, IgA, IgE, and IgD. The IgG segment registered the largest market share in 2022.- Based on application, the APAC intravenous immunoglobulin market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency diseases, myasthenia gravis (MG), multifocal motor neuropathy (MMN), idiopathic thrombocytopenic purpura (ITP), inflammatory myopathies, specific antibody deficiency (SDA), Guillain-Barre syndrome (GBS), and others. The immunodeficiency diseases segment registered the largest market share in 2022.
- Based on distribution channel, the APAC intravenous immunoglobulin market is segmented into hospital pharmacy, retail pharmacy, and others. The hospital pharmacy segment registered the largest market share in 2022.
- Based on end user, the APAC intravenous immunoglobulin market is segmented into hospitals, specialty clinics, and others. The hospitals segment registered the largest market share in 2022.
- Based on country, the market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China dominated the market in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Intravenous Immunoglobulin Market - By Type
1.3.2 APAC Intravenous Immunoglobulin Market - By Application
1.3.3 APAC Intravenous Immunoglobulin Market - By Distribution Channel
1.3.4 APAC Intravenous Immunoglobulin Market - By End User
1.3.5 APAC Intravenous Immunoglobulin Market - By Country
2. APAC Intravenous Immunoglobulin Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Intravenous Immunoglobulin Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Intravenous Immunoglobulin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Immunodeficiency Diseases
5.1.2 Increasing Geriatric Population
5.2 Market Restraints
5.2.1 Adverse Effects of Immunoglobulin Therapy
5.3 Market Opportunities
5.3.1 Growing Pharmaceutical Industry
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for IVIG
5.5 Impact Analysis
6. Intravenous Immunoglobulin Market- APAC Analysis
6.1 APAC Intravenous Immunoglobulin Market Revenue Forecast and Analysis
7. APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028- by Type
7.1 Overview
7.2 APAC Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)
7.3 IgG
7.3.1 Overview
7.3.2 IgG Revenue and Forecast to 2028 (US$ Million)
7.4 IgM
7.4.1 Overview
7.4.2 IgM - Revenue and Forecast to 2028 (US$ Million)
7.5 IgA
7.5.1 Overview
7.5.2 IgA - Revenue and Forecast to 2028 (US$ Million)
7.6 IgE
7.6.1 Overview
7.6.2 IgE - Revenue and Forecast to 2028 (US$ Million)
7.7 IgD
7.7.1 Overview
7.7.2 IgD - Revenue and Forecast to 2028 (US$ Million)
8. APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Application
8.1 Overview
8.2 APAC Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)
8.3 Hypogammaglobulinemia
8.3.1 Overview
8.3.2 Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)
8.4 Chronic Inflammatory Demyelinating Polyneuropathy
8.4.1 Overview
8.4.2 Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)
8.6 Myasthenia Gravis
8.6.1 Overview
8.6.2 Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)
8.7 Multifocal Motor Neuropathy
8.7.1 Overview
8.7.2 Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)
8.8 Idiopathic Thrombocytopenic Purpura
8.8.1 Overview
8.8.2 Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)
8.9 Inflammatory Myopathies
8.9.1 Overview
8.9.2 Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)
8.10 Specific Antibody Deficiency
8.10.1 Overview
8.10.2 Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)
8.11 Guillain-Barre Syndrome
8.11.1 Overview
8.11.2 Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by Distribution Channel
9.1 Overview
9.2 APAC Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others - Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 - by End User
10.1 Overview
10.2 APAC Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others - Market Revenue And Forecasts To 2028 (US$ Million)
11. APAC Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 - Country Analysis
11.1 Overview
11.1.1 Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
11.1.1.1 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.1.3 China: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.1.4 China: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.1.5 China: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.1.6 China: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.1.1.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.2.3 Japan: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.2.4 Japan: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.2.5 Japan: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.2.6 Japan: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.1.1.3 India Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.3.3 India: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.3.4 India: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.3.5 India: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.3.6 India: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.1.1.4 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.4.3 Australia: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.4.4 Australia: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.4.5 Australia: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.4.6 Australia: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.1.1.5 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
11.1.1.5.3 South Korea: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.5.4 South Korea: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.5.5 South Korea: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.5.6 South Korea: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
11.1.1.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Asia Pacific: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Type - 2019-2028 (US$ Million)
11.1.1.6.4 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application - 2019-2028 (US$ Million)
11.1.1.6.5 Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel - 2019-2028 (US$ Million)
11.1.1.6.6 Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User - 2019-2028 (US$ Million)
12. APAC Intravenous Immunoglobulin Market-Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Grifols, S.A.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 ADMA Biologics, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio Products Laboratory Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Shanghai RAAS
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Octapharma AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kedrion S.p.A
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CSL Behring (CSL Limited)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Prothya Biosolutions B.V.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms in Intravenous Immunoglobulin Market
List of Tables
Table 1. APAC Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 3. China: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. China: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 7. Japan: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. India: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 11. India: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. India: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. India: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 15. Australia: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. South Korea: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 19. South Korea: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Type - Revenue and Forecast to 2028 (US$ Million).
Table 23. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market
Table 27. Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market
Table 28. Glossary of Terms in Intravenous Immunoglobulin Market
List of Figures
Figure 1. APAC Intravenous Immunoglobulin Market Segmentation
Figure 2. APAC Intravenous Immunoglobulin Market Segmentation, By Country
Figure 3. APAC Intravenous Immunoglobulin Market Overview
Figure 4. APAC Intravenous Immunoglobulin Market, by Type
Figure 5. APAC Intravenous Immunoglobulin Market, by Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Impact Analysis
Figure 8. APAC Intravenous Immunoglobulin Market- Revenue Forecast and Analysis - 2020 - 2028
Figure 9. APAC Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)
Figure 10. APAC IgG Revenue and Forecasts to 2028 (US$ Million)
Figure 11. APAC IgM - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC IgA - Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC IgE - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. APAC IgD - Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)
Figure 16. APAC Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. APAC Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. APAC Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. APAC Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. APAC Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. APAC Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. APAC Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)
Figure 27. APAC Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. APAC Others - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. APAC Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)
Figure 31. APAC Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 32. APAC Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)
Figure 33. APAC Others- Market Revenue And Forecasts To 2028 (US$ Million)
Figure 34. Asia Pacific Intravenous Immunoglobulin Market Overview, by Country (2022)
Figure 35. Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)
Figure 36. China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Rest of Asia Pacific: Intravenous Immunoglobulin Market - Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ADMA Biologics, Inc.
- Bio Products Laboratory Ltd.
- CSL Behring (CSL Limited)
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Pfizer Inc.
- Prothya Biosolutions B.V.
- Shanghai RAAS
- Takeda Pharmaceutical Company Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 181 |
| Published | December 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2609.61 Million |
| Forecasted Market Value ( USD | $ 4156.85 Million |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Asia Pacific |
